Radient Pharmaceuticals Corporation fka RXPC

[sunspotter]

"Len Bogner: Radient Pharmaceuticals (RPC) update March 31, 2011
Company Update #4
RADIENT PHARMACEUTICALS, INC. (RPC)
Leonard Bogner
President, Bogner Business Associates LLC
March 31, 2011
RPC ($0.46)—AMEX
6-12 Month Target: $3.00-$4.00
Upside Potential: $15.00-$20.00
RATING: SPECULATIVE BUY
www.cpreports.com/?p=974"


You're another poster who for some inexplicable reason has forgotten to include Len Bogner's disclaimer/disclosure which makes it clear that Mr Bogners's so-called research isn't actually research, more just printing any old propaganda that RPC tell him too.

I suppose at least he has a disclosure, which I suspect is more than most paid RPC promoters do:


"Disclosure:
The information contained in this Report contains forward-looking statements relating to the developments of the featured company’s products, services and future operating results or the future of the market. Statements contained in writing or in interviews are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected.

..... These statements have not been independently verified by the officers, directors or employees of Corporate Profile, LLC .com.

The information on this Internet Site has been submitted by journalists and analysts or provided by the companies contained herein or other sources believed to be reliable. Corporate Profile, LLC has not independently verified the information provided to it by third parties. Each individual should perform his or her own independent analysis before investing. The information contained herein is neither an offer nor a solicitation to buy any of the securities of the companies contained herein. Investing in securities is speculative and contains a high element of risk.

Corporate Profile, LLC has been paid a fee by some of the companies featured on our www.corporateprofile.com site which the site links to this Internet Site and it’s[sic] video’s [sic] appear on this site, for investor relations services"

http://www.cpreports.com/?page_id=99

Along with Dew Diligence's observation that failure to file a 10k on schedule is highly indicative of a scam, I would add that the promotion of a stock by disreputable companies like Corporate Profile, LLC, is another sure fire reminder to watch your pockets closely, because the object of their coverage is invariably trying to pick them while you are distracted.

The inability of the publisher to distinguish between possessive "its" and the abbreviated "it's" is without doubt the clincher when deciding whether to pay attention to these puffs, and Corporate Profile fails this test too.